Shareholders Equity and Capital Stock (Details 5) |
9 Months Ended |
|---|---|
|
Sep. 30, 2020
USD ($)
$ / shares
shares
| |
| Warrant [Member] | |
| Exercise price | $ / shares | $ 0.90 |
| Number of warrants | shares | 22,062,878 |
| Remaining contractual life (years) | 1 year 3 months 18 days |
| Aggregate Intrinsic Value | $ | $ 0 |
| Exercise price $1.00 | |
| Exercise price | $ / shares | $ 1.00 |
| Number of warrants | shares | 13,062,878 |
| Remaining contractual life (years) | 1 year |
| Aggregate Intrinsic Value | $ | $ 0 |
| Expiry | 25-Sep-21 |
| Exercise price $0.75 | |
| Exercise price | $ / shares | $ 0.75 |
| Number of warrants | shares | 9,000,000 |
| Remaining contractual life (years) | 1 year 9 months 18 days |
| Aggregate Intrinsic Value | $ | $ 0 |
| Expiry | 04-Aug-22 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|